Skip to main content

Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting

Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320

SOUTH JORDAN, Utah, March 05, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today a series of events for clinicians attending the 2024 SIR Annual Meeting. These educational events will take place at Merit’s headquarters and at SIR booth 320.

On March 26, Merit will host an Evening of Innovation at its Salt Lake City headquarters from 6:30 p.m.– 9:00 p.m. During the evening, guests will hear from Merit’s Chairman and CEO, Fred Lampropoulos, attend a reception, tour Merit’s manufacturing facility, and learn firsthand about Merit’s history of innovation.

Throughout SIR, Merit will host the following educational events at booth 320:

  • “The Surfacer® Inside-Out® System, a Safe and Approved Procedure to Restore and Preserve Vascular Access in Chronically Occluded Central Veins”
    with Amir Noor, MD Interventional Radiologist (Monday, March 25, 2:35 p.m.–2:55 p.m.)
  • “Steerable Vertebral Augmentation & RF Ablation in an Office Setting”
    with Dana Dunleavy, MD Interventional Radiologist (Tuesday, March 26, 12:00 p.m.–1:00 p.m.)
  • “Access: The Good to Know and the Must Know”
    with Darren Klass, MD Interventional Radiologist (Tuesday, March 26, 2:35 p.m.–2:55 p.m.)
  • “PAE: Key Concepts in Patient Selection, Technical Success, and Optimizing Clinical Outcomes.”
    with Jason Hoffmann, MD Interventional Radiologist (Wednesday, March 27, 12:00 p.m.–1:00 p.m.)

Register for these educational events.

“We welcome SIR and its members to Salt Lake City, home of Merit’s corporate headquarters and where Merit was founded thirty-seven years ago,” said Mr. Lampropoulos. “As a supporter of SIR, we share the organization’s commitment to educational opportunities and clinical research to advance the practice of interventional radiology. We are excited to share Merit’s full scope of interventional radiology offerings and solutions with this distinguished audience, furthering our mission to improve patient lives.”

ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 700 individuals. Merit employs approximately 7,000 people worldwide. 

TRADEMARKS Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.

CONTACTS 
PR/Media Inquiries 
Sarah Comstock 
Merit Medical 
+1-801-432-2864 | sarah.comstock@merit.com

INVESTOR INQUIRIES 
Mike Piccinino, CFA, IRC 
Westwicke – ICR 
+1-443-213-0509 | mike.piccinino@westwicke.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.